Imaging News and Research

RSS

MRS could be effective for identifying diabetes

Researchers have long suspected that overweight people tend to have large fat deposits in their pancreases, but they've been unable to confirm or calculate how much fat resides there because of the organ's location.

22 Sep 2009

New device for identifying eye conditions in infants

Tell-tale signs of a condition that can blind premature babies are being seen for the first time using a new handheld device in a study at Duke University Medical Center.

22 Sep 2009

ART to report on its molecular imaging products research at the World Molecular Imaging Congress

ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that current research relating to its molecular imaging products will be presented at poster sessions at the World Molecular Imaging Congress (WMIC), being held at the Palais des congres in Montreal, Canada, from September 23 to 26, 2009.

22 Sep 2009

New 3D/4D ultrasound system from MEDISON

MEDISON (CEO: Wongihl Sohn, www.medison.com), has announced the launch of a new dedicated high performance OB/GYN ultrasound system, featuring the industry's first multi-rendering 3D/4D technology, 3D MXI(TM) (3D Multi-eXtended Imaging(TM)) - ACCUVIX V20 'Prestige.'

22 Sep 2009

Barrington Medical Imaging and Echoserve as service providers for medical imaging equipment

Barrington Medical Imaging, LLC and Echoserve, Inc. The two companies will be combined to create a nationwide, independent service provider for medical imaging equipment across multiple modalities and vendor platforms.

22 Sep 2009

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

Neurodegenerative disorders called frontotemporal dementias (FTD) are the second-leading cause of early-onset dementia in persons under age 65 and can emerge sometimes as early as age 20.

21 Sep 2009

The Transcatheter Cardiovascular Therapeutics 2009 to feature PLCs' RenalGuard System

PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate its RenalGuard System(TM) at Transcatheter Cardiovascular Therapeutics (TCT) 2009, sponsored by the Cardiovascular Research Foundation, September 21 - 25, 2009, in San Francisco, California. More than 11,000 clinicians and professionals are expected to attend this event.

21 Sep 2009

Cyntellect releases new cell cytometry system

Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company’s new platform for non-invasive in situ live cell imaging.

21 Sep 2009

Better visualization of soft tissues using Toshiba's LCI

To continue its commitment to advancing medical imaging technology and improving diagnosis, Toshiba America Medical Systems, Inc. introduces Low-Contrast Imaging (LCI) for Toshiba’s InfinixTM-i systems with mid (12” x 12”) and large (12” x 16”) flat-panel detectors (FPD). Toshiba will demonstrate its low-contrast imaging capabilities at this year’s Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 – Sept. 25, 2009 (Booth #705).

21 Sep 2009

ICTs play a major role in the health care sector

Today the GridTalk project launches its 8th GridBriefing at the Enabling Grids for E-sciencE (EGEE) conference in Barcelona. The report covers how information and communication technologies (ICTs), particularly computing grids, are used in the health and biomedical sectors of European research. EGEE has supported this research community since the project's birth and it is the second largest user group after physics research.

21 Sep 2009

Iodinated, Gadolinium based contrast agents do not negatively affect patients

Iodinated and Gadolinium based contrast agents, frequently used during computed tomography (CT) and MRI scans to aid in the imaging process, are associated with a very low rate of adverse effects, according to a large cohort study published in the October issue of the American Journal of Roentgenology (AJR).

21 Sep 2009

ECG gating reduces patient radiation dose during CT angiography

...

21 Sep 2009

Modified catheter to prevent patient injuries

Though rare, IV contrast material administration can sometimes result in patient injury. However researchers have developed a modified catheter that may prevent such events from occurring, according to a study in the October issue of the American Journal of Roentgenology (AJR).

21 Sep 2009

Researchers receive grants to study Alzheimer's disease

Five early-career scientists were awarded The Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease. The $75,000 awards provide a broad array of funding in the biological, genetic, and environmental causes of AD.

21 Sep 2009

Center for Hip Pain and Preservation focuses on improved understanding of hip abnormalities

Recent improved understanding of hip abnormalities, combined with advances in diagnostic imaging techniques and minimally invasive surgical treatments are giving many patients new hope for relieving chronic, misdiagnosed hip pain.

21 Sep 2009

Young drinkers to be more susceptible to alcohol dependence

The age at which a person takes a first drink may influence genes linked to alcoholism, making the youngest drinkers the most susceptible to severe problems.

21 Sep 2009

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend MedAxiom’s Fall Conference in Dana Point, California September 23rd, 2009 to promote their cardiac optimized PET scanner, the Attrius™ (www.medaxiom.com).

19 Sep 2009

AMR finds 75 percent of hetastarch recipients underwent surgical procedures

Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that for the January - May 2009 time period, a significantly higher percentage of hetastarch recipients (75%) underwent a surgical procedure when compared to those receiving albumin/plasma protein fraction (51%).

19 Sep 2009

Analysis project inflation rates for healthcare supplies to remain unchanged through 2010

Inflation rates for healthcare supplies are projected to remain unchanged through 2010, according to an analysis released by the Premier healthcare alliance.

18 Sep 2009

InSight's fourth quarter 2009 revenues decreases by 17.3% year-on-year

InSight Health Services Holdings Corp. (“InSight”) (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.

18 Sep 2009